331 related articles for article (PubMed ID: 20736988)
1. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Leelahavanichkul A; Yan Q; Hu X; Eisner C; Huang Y; Chen R; Mizel D; Zhou H; Wright EC; Kopp JB; Schnermann J; Yuen PS; Star RA
Kidney Int; 2010 Dec; 78(11):1136-53. PubMed ID: 20736988
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
4. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
Aritomi S; Koganei H; Wagatsuma H; Mitsui A; Ogawa T; Nitta K; Konda T
Heart Vessels; 2010 Nov; 25(6):549-55. PubMed ID: 20922532
[TBL] [Abstract][Full Text] [Related]
5. CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis.
Xia Y; Jin X; Yan J; Entman ML; Wang Y
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1422-8. PubMed ID: 24855055
[TBL] [Abstract][Full Text] [Related]
6. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.
Nakano D; Lei B; Kitada K; Hitomi H; Kobori H; Mori H; Deguchi K; Masaki T; Minamino T; Nishiyama A
Am J Hypertens; 2012 Mar; 25(3):354-8. PubMed ID: 22113172
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
[TBL] [Abstract][Full Text] [Related]
9. Model of robust induction of glomerulosclerosis in mice: importance of genetic background.
Ma LJ; Fogo AB
Kidney Int; 2003 Jul; 64(1):350-5. PubMed ID: 12787428
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.
Souza AC; Bocharov AV; Baranova IN; Vishnyakova TG; Huang YG; Wilkins KJ; Hu X; Street JM; Alvarez-Prats A; Mullick AE; Patterson AP; Remaley AT; Eggerman TL; Yuen PS; Star RA
Kidney Int; 2016 Apr; 89(4):809-22. PubMed ID: 26994575
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
12. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.
Tian M; Tang L; Wu Y; Beddhu S; Huang Y
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F558-F571. PubMed ID: 29873514
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CX
Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
Nishihara M; Takesue K; Hirooka Y
Clin Exp Hypertens; 2019; 41(3):211-219. PubMed ID: 29694249
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
Xiao L; Xu B; Zhou L; Tan RJ; Zhou D; Fu H; Li A; Hou FF; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1313-1322. PubMed ID: 30710617
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
19. A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading.
Tsukamoto Y; Mano T; Sakata Y; Ohtani T; Takeda Y; Tamaki S; Omori Y; Ikeya Y; Saito Y; Ishii R; Higashimori M; Kaneko M; Miwa T; Yamamoto K; Komuro I
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1658-67. PubMed ID: 24043257
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
